In-vitro Antioxidant, In-vitro and In-silico Ovarian Anticancer Activity (Ovarian Cancer Cells-PA1) and Phytochemical Analysis of Cissus quadrangularis L. Ethanolic Extract


Cite item

Full Text

Abstract

Background:Cissus quadrangularis is a valuable natural source of traditional medicines.

Objective:An in vitro investigation was performed to determine whether the ethanolic extract from the whole portions of C. quadrangularis had anticancer and free radical scavenging activities against ovarian cancer cells-PA1. C. quadrangularis is a herb collected from rural areas in Andhra Pradesh, India.

Materials and Methods:C. quadrangularis was air-dried and crushed, and the powder and ethanol (0.5 kg) were used in a Soxhlet device for continuous extraction. Phytochemical analysis of the extracts was performed using a standard procedure. The antioxidant activity of the ethanolic extract of C. quadrangularis was evaluated using DPPH. An in vitro anticancer study used an ethanolic extract against the PA1 cell line. Apoptosis of ovarian cancer cells was studied using DAPI and carboxy-H2DCFDA staining. From LC-MS analysis, quercetin-3-O-alpha-Lrhamnopyranoside and erucic acid were docked with the threonine tyrosine kinase (TTK) enzyme using auto docking.

Results:The ethanolic extract of C. quadrangularis demonstrated significant dose-dependent antioxidant activity compared to ascorbic acid. The ethanolic extract of C. quadrangularis was found to have high anticancer activity against ovarian cancer cell lines (PA1), with an IC50 value of 482.057 ± 113.857 µg/ml. DAPI and carboxy-H2DCFDA staining confirmed that C. quadrangularis ethanolic extract induced apoptosis in ovarian cancer cells (p < .001). Molecular docking studies helped identify the binding affinities between the protein and ligand complexes, such as Quercetin-3-O-alpha-Lrhamnopyranoside binding sites of target proteins 5N7V (MET602, GLN672) and erucic acid 5N7V (GLY354). Quercetin-3-O-alpha-L-rhamnopyranoside was reported to bind with 5N7V by hydrogen bonding at MET602 and GLN672 amino acids with 2.02, 2.99 Å bonding length distance and binding affinity of -7.9 kcal/mol. Erucic acid was reported to bind with 5N7V by hydrogen bonding at GLY354 amino acid with 3.18, 2.93 Å bonding length (Å) distance and binding affinity of -4.3 kcal/mol. The current analysis showed that the ethanolic extracts of C. quadrangularis L. exhibited antioxidant and anticancer properties against ovarian PA1 cells.

Conclusion:The experimental results confirmed that C. quadrangularis L. is a promising, safe chemotherapeutic plant for ovarian cancer PA1 cells. The docking results demonstrated that Quercetin-3-O-alpha-L-rhamnopyranoside strongly binds threonine tyrosine kinase at the MET602 and GLN672 positions. This study showed that the C. quadrangularis ethanolic extract has Quercetin-3-O-alpha-L-rhamnopyranoside, which can be used as an anticancer agent.

About the authors

Xuejing Zhao

Department of Obstetrics and Gynecology,, Air Force Medical University

Email: info@benthamscience.net

Yinghui Wang

Department of Gynaecology,, People's Hospital of Laoling City

Email: info@benthamscience.net

Zhaohui Zhang

Department of Gynaecology, People's Hospital of Laoling City

Email: info@benthamscience.net

Periyannan Velu

Department of Biotechnology, Faculty of Science,, Annamalai University,

Email: info@benthamscience.net

Runping Liu

Department of Obstetrics and Gynecology, Hanzhong People’s Hospital,

Author for correspondence.
Email: info@benthamscience.net

References

  1. Palanisamy, C.P.; Cui, B.; Zhang, H.; Panagal, M.; Paramasivam, S.; Chinnaiyan, U.; Jeyaraman, S.; Murugesan, K.; Rostagno, M.; Sekar, V.; Natarajan, S.P. Anti-ovarian cancer potential of phytocompound and extract from South African medicinal plants and their role in the development of chemotherapeutic agents. Am. J. Cancer Res., 2021, 11(5), 1828-1844. PMID: 34094656
  2. Zaorsky, N.G.; Churilla, T.M.; Egleston, B.L.; Fisher, S.G.; Ridge, J.A.; Horwitz, E.M.; Meyer, J.E. Causes of death among cancer patients. Ann. Oncol., 2017, 28(2), 400-407. doi: 10.1093/annonc/mdw604 PMID: 27831506
  3. Ambrus, J.L.; Ambrus, C.M.; Mink, I.B.; Pickren, J.W. Causes of death in cancer patients. J. Med., 1975, 6(1), 61-64. PMID: 1056415
  4. Rastogi, A. Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma. World J. Gastroenterol., 2018, 24(35), 4000-4013. doi: 10.3748/wjg.v24.i35.4000 PMID: 30254404
  5. Nikhitha, J.N.; Swathy, K.S.; Chandran, R.P. In vitro anticancer activity of ethanol extract of Adhatoda vasica Nees on human ovarian cancer cell lines. J. Genet. Eng. Biotechnol., 2021, 19(1), 116. doi: 10.1186/s43141-021-00215-1 PMID: 34351536
  6. Lawton, F.G.; Pavlik, E.J. Perspectives on Ovarian Cancer 1809 to 2022 and Beyond. Diagnostics (Basel), 2022, 12(4), 791. doi: 10.3390/diagnostics12040791 PMID: 35453839
  7. Burges, A.; Schmalfeldt, B. Ovarian cancer: Diagnosis and treatment. Dtsch. Arztebl. Int., 2011, 108(38), 635-641. PMID: 22025930
  8. a) Friedlander, M.; Trimble, E.; Tinker, A.; Alberts, D.; Avall-Lundqvist, E.; Brady, M.; Harter, P.; Pignata, S.; Pujade-Lauraine, E.; Sehouli, J.; Vergote, I. Clinical trials in recurrent ovarian cancer. Int. J. Gynecol. Cancer, 2011, 21(4), 771-775. doi: 10.1097/IGC.0b013e31821bb8aa; b) Akter, S.; Rahman, M.A.; Hasan, M.N.; Akhter, H.; Noor, P.; Islam, R.; Shin, Y.; Rahman, M.D.H.; Gazi, M.S.; Huda, M.N.; Nam, N.M.; Chung, J.; Han, S.; Kim, B.; Kang, I.; Ha, J.; Choe, W.; Choi, T.G.; Kim, S.S. Recent advances in ovarian cancer: Therapeutic strategies, potential biomarkers, and technological improvements. Cells, 2022, 11(4), 650. doi: 10.3390/cells11040650 PMID: 35203301
  9. Sasidharan, S.; Chen, Y.; Saravanan, D.; Sundram, K.M.; Yoga Latha, L. Extraction, isolation and characterization of bioactive compounds from plants’ extracts. Afr. J. Tradit. Complement. Altern. Med., 2011, 8(1), 1-10. PMID: 22238476
  10. Bupesh, G.; Begum, R.; Vasanthi, M.; Kamalapathy, M.; Bupesh, G.; Sahoo, U. A short review on pharmacological activity of Cissus quadrangularis. Bioinformation, 2020, 16(8), 579-585. doi: 10.6026/97320630016579 PMID: 33214745
  11. Tuy-on, T.; Itharat, A.; Maki, P.; Thongdeeying, P.; Pipatrattanaseree, W.; Ooraikul, B. In Vitro Cytotoxic activity against breast, cervical, and ovarian cancer cells and flavonoid content of plant ingredients used in a selected thai traditional cancer remedy: correlation and hierarchical cluster analysis. Evid. Based Complement. Alternat. Med., 2020, 2020, 1-10. doi: 10.1155/2020/8884529 PMID: 33281918
  12. Senguttuvan, J.; Paulsamy, S.; Karthika, K. Phytochemical analysis and evaluation of leaf and root parts of the medicinal herb, Hypochaeris radicata L. for in vitro antioxidant activities. Asian Pac. J. Trop. Biomed., 2014, 4(Suppl. 1), S359-S367. doi: 10.12980/APJTB.4.2014C1030 PMID: 25183112
  13. Patil, S.P. Proton NMR and HR-LC/MS based phytochemical analysis of methanolic fraction of Alectra parasitica A. Rich. rhizomes. Heliyon, 2020, 6(1), e03171.
  14. Shilpa, VP; Muddukrishnaiah, K; Thavamani, BS; Dhanapal, V; Arathi, KN; Vinod, KR; Sreeranjini, SR In vitro immunomodulatory, antifungal, and antibacterial screening of Phyllanthus niruri against to human pathogenic microorganisms. Environ. Dis, 2018, 3(3), 63.
  15. Bafna, P.S.; Patil, P.H.; Maru, S.K.; Mutha, R.E. Cissus quadrangularis L: A comprehensive multidisciplinary review. J. Ethnopharmacol., 2021, 279, 114355. doi: 10.1016/j.jep.2021.114355 PMID: 34181958
  16. Thakur, A.; Jain, V.; Hingorani, L.; Laddha, K. Phytochemical studies on cissus quadrangularis linn. Pharmacognosy Res., 2009, 1(4), 213-221.
  17. Muddukrishnaiah, K.; Sumita, S. Antimicrobial, synergistic activity and antioxidant studies on multidrug resistance human pathogen using crude extract of Azadirachta indica leaf and Withania somnifera rhizome. J. Plant Pathol. Microbiol., 2015, 2015, 1-3.
  18. Saraf, S.; Kaur, C.D. Phytoconstituents as photoprotective novel cosmetic formulations. Pharmacogn. Rev., 2010, 4(7), 1-11. doi: 10.4103/0973-7847.65319 PMID: 22228936
  19. Kumar, A. P, N.; Kumar, M.; Jose, A.; Tomer, V.; Oz, E.; Proestos, C.; Zeng, M.; Elobeid, T.; K, S.; Oz, F. Major phytochemicals: Recent advances in health benefits and extraction method. Molecules, 2023, 28(2), 887. doi: 10.3390/molecules28020887 PMID: 36677944
  20. Wu, D.; Yotnda, P. Production and detection of reactive oxygen species (ROS) in cancers. J. Vis. Exp., 2011, (57), 3357. PMID: 22127014
  21. Kim, D.S.; Jeon, B.K.; Lee, Y.E.; Woo, W.H.; Mun, Y.J. Diosgenin induces apoptosis in HepG2 cells through generation of reactive oxygen species and mitochondrial pathway. Evid. Based Complement. Alternat. Med., 2012, 2012, 1-8. doi: 10.1155/2012/981675 PMID: 22719792
  22. Kumar, G; Gupta, R; Sharan, S; Roy, P; Pandey, DM Anticancer activity of plant leaves extract collected from a tribal region of India. 3 Biotech, 2019, 9(11), 399.
  23. Khan, T.; Ali, M.; Khan, A.; Nisar, P.; Jan, S.A.; Afridi, S.; Shinwari, Z.K. Anticancer plants: A review of the active phytochemicals, applications in animal models, and regulatory aspects. Biomolecules, 2019, 10(1), 47. doi: 10.3390/biom10010047 PMID: 31892257
  24. Shah, K.A.; Brahmkshatriya, H.R.; Ananthkumar, G.B.; Brahmkshatriya, M. Clinical evaluation of Cissus quadrangularis as osteogenic agent in maxillofacial fracture: A pilot study. Ayu, 2015, 36(2), 169-173. doi: 10.4103/0974-8520.175542 PMID: 27011718
  25. Ashraf, M.A. Phytochemicals as potential anticancer drugs: Time to ponder nature’s bounty. BioMed Res. Int., 2020, 2020, 1-7. doi: 10.1155/2020/8602879 PMID: 32076618
  26. Vijayalakshmi, V.; Sadanandan, B.; Anjanapura, R.V. In vitro comparative cytotoxic assessment of pristine and carboxylic functionalized multiwalled carbon nanotubes on LN18 cells. J. Biochem. Mol. Toxicol., 2023, 37(3), e23283. doi: 10.1002/jbt.23283 PMID: 36541368

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers